company background image
0P8 logo

Penumbra DB:0P8 Stock Report

Last Price

€202.00

Market Cap

€7.9b

7D

-7.3%

1Y

-20.5%

Updated

26 Mar, 2024

Data

Company Financials +

0P8 Stock Overview

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally.

0P8 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance3/6
Financial Health6/6
Dividends0/6

Penumbra, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Penumbra
Historical stock prices
Current Share PriceUS$202.00
52 Week HighUS$314.00
52 Week LowUS$168.00
Beta0.52
1 Month Change-7.34%
3 Month Change-12.93%
1 Year Change-20.47%
3 Year Change-8.18%
5 Year Change57.46%
Change since IPO466.22%

Recent News & Updates

Recent updates

Shareholder Returns

0P8DE Medical EquipmentDE Market
7D-7.3%-0.6%1.6%
1Y-20.5%2.8%6.4%

Return vs Industry: 0P8 underperformed the German Medical Equipment industry which returned 2.8% over the past year.

Return vs Market: 0P8 underperformed the German Market which returned 6.4% over the past year.

Price Volatility

Is 0P8's price volatile compared to industry and market?
0P8 volatility
0P8 Average Weekly Movement5.6%
Medical Equipment Industry Average Movement5.0%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.2%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 0P8 has not had significant price volatility in the past 3 months.

Volatility Over Time: 0P8's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20044,200Adam Elsesserhttps://www.penumbrainc.com

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands.

Penumbra, Inc. Fundamentals Summary

How do Penumbra's earnings and revenue compare to its market cap?
0P8 fundamental statistics
Market cap€7.86b
Earnings (TTM)€83.91m
Revenue (TTM)€976.59m

93.7x

P/E Ratio

8.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0P8 income statement (TTM)
RevenueUS$1.06b
Cost of RevenueUS$375.88m
Gross ProfitUS$682.64m
Other ExpensesUS$591.69m
EarningsUS$90.95m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)2.35
Gross Margin64.49%
Net Profit Margin8.59%
Debt/Equity Ratio0%

How did 0P8 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.